Author： Hoshino Junichi Ubara Yoshifumi Ohashi Kenichi Takemoto Fumi Takaichi Kenmei
Publisher： Oxford University Press
ISSN： 1753-0784
Source： NDT PLUS, Vol.1, Iss.6, 2008-12, pp. : 414-416
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Although primary systemic amyloid light-chain amyloidosis was considered intractable, recent advances in therapy have been reported to result in better clinical outcomes including remission of nephrotic syndrome. However, changes in renal pathologic findings after high-dose chemo- therapy have not been characterized. We describe a patient who underwent serial renal biopsies and had complete remission after high-dose melphalan and autologous stem cell transplantation for this form of amyloidosis. Successive renal biopsy specimens showed reduction in amyloid staining mainly in interlobular arterial and arteriolar walls. Thus, amyloid light-chain amyloidosis resolved both clinically and pathologically after high-dose chemotherapy.
Related content
Neurological Complications after Autologous Stem Cell Transplantation
European Neurology, Vol. 41, Iss. 1, 1999-01 ,pp. :
Access to resources
Recommend
By Söderholm J. D. Malm C. Juliusson G. Sjödahl R.
Scandinavian Journal of Gastroenterology, Vol. 37, Iss. 5, 2002-05 ,pp. :
Primary Systemic Amyloidosis with Extensive Gastrointestinal Involvement
Case Reports in Gastroenterology, Vol. 7, Iss. 3, 2013-12 ,pp. :